The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But clearly the more you drive the system um with NMN um the more you're going to yield uh these and we can measure not only how much did your homoyine go up by the way up to 15 from from typical seven. Wow. That's a big jump.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
CD38 not only cleaves NAD but it also cleaves NMN which is one of the one of the two one of the two precursors NN and NR. So when you actually are have increased CD38 activity and you take NMN you churn through this pathway and actually you increase your nicotenomide and you increase its methylation.